BABUDIERI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 5.285
EU - Europa 3.128
AS - Asia 1.416
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 10
SA - Sud America 7
Totale 9.884
Nazione #
US - Stati Uniti d'America 5.251
UA - Ucraina 1.239
CN - Cina 1.096
DE - Germania 471
SE - Svezia 409
IT - Italia 399
SG - Singapore 178
FR - Francia 163
FI - Finlandia 161
GB - Regno Unito 128
CZ - Repubblica Ceca 57
TR - Turchia 33
BE - Belgio 30
CA - Canada 29
IN - India 29
AU - Australia 23
KR - Corea 23
HK - Hong Kong 21
RO - Romania 16
IR - Iran 13
EU - Europa 10
NL - Olanda 8
BG - Bulgaria 7
JP - Giappone 7
ES - Italia 5
PL - Polonia 5
HU - Ungheria 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
BR - Brasile 3
IL - Israele 3
KE - Kenya 3
LU - Lussemburgo 3
PH - Filippine 3
SA - Arabia Saudita 3
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
MK - Macedonia 2
MX - Messico 2
MZ - Mozambico 2
NG - Nigeria 2
NO - Norvegia 2
PT - Portogallo 2
RU - Federazione Russa 2
AM - Armenia 1
AR - Argentina 1
BT - Bhutan 1
CH - Svizzera 1
EC - Ecuador 1
EG - Egitto 1
HR - Croazia 1
ID - Indonesia 1
IQ - Iraq 1
IS - Islanda 1
ML - Mali 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
TH - Thailandia 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.884
Città #
Chandler 1.432
Jacksonville 735
Princeton 466
Nanjing 303
Dearborn 286
New York 230
Wilmington 191
Sassari 157
Ann Arbor 130
Nanchang 126
Boardman 122
Singapore 114
Beijing 105
Shenyang 101
Woodbridge 81
Ashburn 66
Hebei 66
Brno 55
Tianjin 54
Changsha 52
Munich 39
Jiaxing 38
Ningbo 36
Jinan 35
Rome 34
Kunming 33
Zhengzhou 32
Andover 31
Norwalk 31
Brussels 30
San Francisco 26
Toronto 24
Seoul 23
Hangzhou 22
Cagliari 21
Guangzhou 21
Taizhou 21
Dallas 20
Izmir 18
Hong Kong 16
Leawood 16
Mountain View 15
Lanzhou 14
Changchun 13
Los Angeles 13
Helsinki 12
Milan 12
Ardabil 11
Falls Church 11
San Mateo 11
Auburn Hills 10
Washington 10
Sydney 8
Alghero 7
Haikou 7
Turin 7
Frankfurt am Main 6
Melbourne 6
Orange 6
Sofia 6
Tokyo 6
Canberra 5
Chicago 5
Edinburgh 5
Hefei 5
Lappeenranta 5
Monmouth Junction 5
Amsterdam 4
Budapest 4
London 4
Paris 4
Augusta 3
Bologna 3
Cedar Knolls 3
Genova 3
Gonnosfanàdiga 3
Huskvarna 3
Luxembourg 3
Montreal 3
Mumbai 3
Naples 3
Palermo 3
Radomsko 3
Redmond 3
Assemini 2
Bari 2
Beira 2
Bratislava 2
Bultei 2
Büdelsdorf 2
Central 2
Città Di Castello 2
Copenhagen 2
Dublin 2
Haifa 2
Hanover 2
Horia 2
Houston 2
Islington 2
Lagos 2
Totale 5.747
Nome #
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 111
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 87
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 85
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 81
Dental care and HIV-infected individuals: are they equally treated? 78
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 76
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 76
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 74
Epidemiological investigation of a Varicella outbreak in an Italian Prison 71
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 69
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 67
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 67
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 65
A young woman with hepatitis after a sore throat 65
Enterococcal infections of the respiratory tract in HIV patients 64
Application of a miniaturized system to the study of the intestinal microflora 64
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 63
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 63
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 62
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 62
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 62
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 61
Evidence for cross infection in an outbreak of Clostridium difficile associated diarrhoea in a surgical unit 61
Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients 61
Directly Observed Therapy to treat HIV Infection in Prisoners 60
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 60
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 59
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 59
Evaluation of EZH2 expression in hepatitis B patients 59
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 59
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 59
HIV related aneurisms 59
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 58
Prevalenza e fattori di rischio dell’infezione da Mycobacterium tuberculosis in una popolazione detenuta in Italia 58
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 58
Early abnormalities of antibody response against Mycobacterium tuberculosis in the Human Immunodeficiency Virus infection 56
Diarrea associata a Clostridium spiroforme 56
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 56
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 56
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 56
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 56
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 55
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 55
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 55
Sodoku in: "Enciclopedia Medica Italiana" II^ edizione USES edizioni scientifiche edt. 1987; vol. XIV; p. 458-62 55
Diarrhoea associated with toxigenic Clostridium spiroforme 54
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 54
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 54
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 53
Course of patients coinfected with HIV and hepatotropic viruses 53
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 53
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 53
Epidemiologia dell'infezione da HIV nel nord della Sardegna 53
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 53
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 53
An outbreak of Q fever in a prison in Italy 52
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 52
Guidelines of Tuberculosis preventive therapy for HIV-infected persons: a prospective, multicentre study 52
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 52
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 52
HNK1 perifereal blood lymphocytes in HIV infected patients 52
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 52
“Risk factors and outcome in a large cohort of acute hepatitis C patients” 51
Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection 51
Tache Noire in a Patient with Acute Q Fever 51
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 51
Tuberculosis and Human Immunodeficiency Virus Infection in Italy. Preliminary results from a multicenter study 51
Eritema cronico migrante 51
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 50
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 50
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 50
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 50
La diagnosi rapida delle infezioni gastrointestinali. Vibrioni, Campylobacter e Yersinia 50
Tuberculosis and AIDS: a retrospective, longitudinal, multicentre study of Italian AIDS patients 49
Epidemiology of HIV1 infection in the island of Sardinia 49
Isolation of Clostridium difficile from human jejunum: identification of a reservoir for the disease? 49
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 49
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 49
Drug-Resistant Tuberculosis in HIV-Infected Persons: Italy 1999–2000 49
Programma italiano di studio tubercolosi ed AIDS: risultati preliminari 49
Epidemie da Clostridium difficile in reparti di chirurgia 48
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 48
Elevated Serum IgG4 Levels in a Young Patient with Polyserositis and Necator americanus Infection 48
Levels of TNF and IL-2R directly correlate to patient's immunological and clinical status. 48
Correlates of HIV, HBV, and HCV infection in a prison inmate population: Results from a multicentre study in Italy 48
Mycobacterial infections in HIV-infected patients in north Sardinia 47
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 47
HIV-related aneurysms 47
La terapia della prostatite batterica cronica. Studio clinico e di laboratorio su 90 casi di prostatite cronica 47
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 47
Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience 47
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 47
Predictivity of HNK1 cells and Neopterin in HIV infection 46
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 46
Risk factors foe Tuberculosis in HIV-infected persons. A prospective cohort study 46
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 46
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 46
The association between education level and chronic liver disease of any etiology” 46
HCV hepatitis and interferon-related depression: An analysis of the retrospective phase of the Probe study 46
First European quality control of cellular phenotyping by flow cytometry 46
Totale 5.632
Categoria #
all - tutte 54.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.512 0 3 146 16 183 245 334 38 208 115 210 14
2020/20211.820 202 5 287 11 211 101 218 35 310 276 121 43
2021/20221.113 170 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/2025183 131 52 0 0 0 0 0 0 0 0 0 0
Totale 10.377